4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-007710
President and COO sold 36,609 shares at $19.05 ($697,519)
- President and COO acquired 36,609 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Metzger Michael A · President and COO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-13 | Exercise or conversion : show line 1 in the form | +2,045 | $7.20 | $14,724 | 19,704 | D |
| 2021-12-13 | Sale : show line 2 in the form | −2,045 | $19.05 | $38,964 | 17,659 | D |
| 2021-12-13 | Exercise or conversion : show line 3 in the form | +34,564 | $6.38 | $220,518 | 52,223 | D |
| 2021-12-13 | Sale : show line 4 in the form | −34,564 | $19.05 | $658,555 | 17,659 | D |
| Open-market sales · 36,609 sh · avg $19.05 · $697,519 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-13 | Exercise or conversion : show line 5 in the form Stock Options (Right to buy) | −2,045 | 0 | D |
| 2021-12-13 | Exercise or conversion : show line 6 in the form Stock Options (Right to buy) | −34,564 | 0 | D |
Loading xslF345X03/primarydocument.xml…